好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Impact of a Brain Death Workshop on the Knowledge of Attendees
Neuro Trauma and Critical Care
P1 - Poster Session 1 (8:00 AM-9:00 AM)
19-001
To assess knowledge about determination of brain death (BD) through surveys completed before, immediately after, and 10-months following a BD Workshop.

Determination of BD is less common and requires different skills than determination of cardiopulmonary death. 好色先生al programs regarding BD determination have proliferated with unknown effects. This study assessed whether a BD workshop led to improved and retained knowledge of participants.
This prospective observational study was conducted in the United Arab Emirates (UAE). A survey pertinent to BD determination in children and adults based on the 2023 好色先生 Guidelines was administered to all participants at the beginning and end of the Workshop. Participants were asked to complete the survey 10-months later to assess knowledge retention.
The pre-workshop survey had 250 respondents, predominantly 20-59 years old (95%), with a slight male majority (53%). Most participants were physicians (56%) or nurses (30%) and identified as critical care specialists. Prior to the workshop, 47% reported not performing BD evaluations, and 64% had not performed one in the last six months. At the 10-month follow-up, 42% had not performed a BD evaluation. Before the workshop, 62% felt comfortable explaining BD, increasing to 75% immediately after, and remaining high at 75% at 10-month follow-up. Prior to the workshop 48% faced opposition from families when testing for BD, and 46% when withdrawing care, with 19% citing legal restrictions. On follow-up, opposition decreased to 28% for testing and 38% for withdrawing care. Average BD knowledge-based test scores improved from 48% pre-workshop to 71% immediately post-workshop but declined to 50% on 10-month follow-up.
The BD Workshop provided education that persisted. Test scores significantly improved immediately after the workshop but declined to almost pre-test levels on 10-month follow-up. However, there was a sustained gain in comfort explaining BD over the study period. 
Authors/Disclosures
Panayiotis N. Varelas, MD, PhD, FAAN (Albany Med-Department of Neurology)
PRESENTER 		Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca -Alexion - Portola. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca- Alexion-Portola. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Varelas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Giammarco, Mullins & Horton P.C. The institution of Dr. Varelas has received research support from Marinus. The institution of Dr. Varelas has received research support from Bayer. Dr. Varelas has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Rep to the RUC meeting with AAN. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving as a Speaker at the Annual Meeting with AAN. Dr. Varelas has a non-compensated relationship as a President - Past President with Neurocritical Care Society that is relevant to AAN interests or activities.
Haamid H. Siddique, MBBS Dr. Siddique has nothing to disclose.
Yasser B. Abulhasan, MD Dr. Abulhasan has nothing to disclose.
Maria P. Gomez, MD Dr. Gomez has nothing to disclose.
Amina Randhawa, MSc, MPhil Mrs. Randhawa has nothing to disclose.
Matthew Kirschen, MD, PhD, FAAN The institution of Dr. Kirschen has received research support from NIH.
Lori A. Shutter, MD, FCCM, FNCS, FAAN, FAAN (UPMC Dept of Critical Care Medicine) The institution of Dr. Shutter has received research support from NIH. Dr. Shutter has received publishing royalties from a publication relating to health care.